A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer

Lung cancer is one of the most common forms of cancer. One common type is non-small cell lung cancer (NSCLC). NSCLC happens when abnormal cells in the lungs grow too fast. This can stop the lungs from working normally. NSCLC can be divided into types based on where cancer starts. Some NSCLC starts in the cells that line the larger airways near the center of the lungs. This is called squamous NSCLC. Other NSCLC often starts in the outer parts of the lungs, in cells that make mucus. This is called nonsquamous NSCLC. This study focuses on squamous and nonsquamous NSCLC in later stages (advanced).

Trial Details

NCT ID
NCT07217301
Phase
PHASE3
Sponsor
Takeda
Status
RECRUITING
Cancer Type
Non-Small Cell (NSCLC) Lung Cancer
Interventions
  • IBI363
  • Control Arm
Locations (sample)
  • Jonesboro, Arkansas, United States|35.8423,-90.70428
  • Fair Oaks, California, United States|38.64463,-121.27217
  • Fountain Valley, California, United States|33.70918,-117.95367
  • Los Alamitos, California, United States|33.80307,-118.07256
  • Torrance, California, United States|33.83585,-118.34063

Key Eligibility Criteria

  • Must be able to understand and willing to sign the written ICF and be able to comply with the visit schedule and related procedures specified in th…
  • Male or female participants must be at least 18 years old or the legal age of majority in their country, whichever is greater. Note: For the Japan-…
  • (a) Squamous NSCLC: Have locally unresectable advanced or metastatic histologically or cytologically confirmed squamous NSCLC. Mixed small cell car…
  • (b) Nonsquamous NLSCLC: Have locally unresectable advanced or metastatic histologically or cytologically confirmed nonsquamous NSCLC. Mixed small c…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Non-Small Cell (NSCLC) Lung Cancer Trials on Trialify →